Abologix ^Company

ABOLOGIX is a company that focuses on developing monoclonal antibodies to target Junction Adhesion Molecule JAM-C and extracellular matrix-related protein. The treatment is specifically designed for cancer patients who are unresponsive to traditional therapies.